CEO of Apellis Pharmaceuticals, Inc.
CEO of Apellis Pharmaceuticals, Inc.
CEO of Apellis Pharmaceuticals, Inc.
CEO of Apellis Pharmaceuticals, Inc.
Education
Medical biochemistry degree from Royal Holloway, University of London
Sector of Economy
Healthcare
Born
January 16, 1976 - 49 years ago
CEO of Apellis Pharmaceuticals, Inc. for
1 year 4 months (Jan 2024 - Present)
Previous Experience
Chief Commercial Officer at Apellis Pharmaceuticals, Inc.; Senior Vice President of Corporate Development at Biogen
Competitors/colleagues of Adam Townsend
See how much did Adam Townsend make over time.
Holdings and trades for CEO of Apellis Pharmaceuticals, Inc.
Holdings and trades for CEO of Apellis Pharmaceuticals, Inc.
No data yet.
No data yet.
Total Stock Sold
$13.33M
$13.33M
219,106 APLS shares
What if they kept their stock?
If Adam Townsend didn't sell their stock, today they would have:
Extra APLS219,106 shares worth $7.03M.
This is -47.27% and $6.30M less than what they got when they sold the stock.
See recent insider trades of Adam Townsend.
$20.52K
APLS at $29.52/share
Jan 29, 2025
Sale
$101.10K
APLS at $30.43/share
Jan 22, 2025
Sale
$65.94K
APLS at $29.96/share
Jan 17, 2025
Sale
$77.07K
APLS at $28.70/share
Jan 13, 2025
Sale
$77.80K
APLS at $67.77/share
Feb 12, 2024
Sale
$58.11K
APLS at $64.14/share
Jan 29, 2024
Sale
$221.83K
APLS at $65.00/share
Jan 22, 2024
Sale
$149.32K
APLS at $66.81/share
Jan 16, 2024
Sale
23,748 shares
APLS
Jan 16, 2024
Received
$6.70M
APLS at $60.90/share
Dec 1, 2023
Sale
See how much did Adam Townsend make over time.
No compensation data available for Adam Townsend yet. Come back soon!
Here are other CEOs of Apellis Pharmaceuticals, Inc.